Description
A metabolite of choline, phosphatidylcholine, and L-carnitine; dietary administration increases renal tubulointerstitial fibrosis, collagen deposition, and Smad3 phosphorylation in mice and increases aortic lesion area in atherosclerosis-prone ApoE-/- mice at 0.12% w/w; plasma levels of TMAO are elevated in patients with chronic kidney disease and decreased in patients with active, compared with inactive, ulcerative colitis; elevated plasma levels of TMAO are associated with increased risk of cardiovascular disease
Formal name: N,N-dimethyl-methanamine, N-oxide
Synonyms: NSC 408426|TMAO
Molecular weight: 75.1
CAS: 1184-78-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Kidney & Renal Disease|Chronic Kidney Disease||Research Area|Endocrinology & Metabolism|Bile Acids & Microbiome||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis